Roberto Bruno
Overview
Explore the profile of Roberto Bruno including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
12
Citations
70
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Spampinato S, Conti G, Marino A, Raimondo V, Celesia B, Pellicano G, et al.
Biomed Rep
. 2024 Oct;
21(6):179.
PMID: 39387001
Bictegravir/emtricitabine/tenofovir alafenamide (B/F/TAF), as a fixed dosed combination, is effective in people living with human immunodeficiency virus (PLWH) previously treated with other therapeutic regimens. The aim of the present retrospective...
2.
Bruno R, Vaccaro U
Entropy (Basel)
. 2024 Apr;
26(4).
PMID: 38667837
We consider the problem of constructing prefix-free codes in which a designated symbol, a , can only appear at the end of codewords. We provide a linear-time algorithm to construct...
3.
Verscharen D, Wicks R, Alexandrova O, Bruno R, Burgess D, Chen C, et al.
Exp Astron (Dordr)
. 2023 Mar;
54(2-3):473-519.
PMID: 36915623
The smallest characteristic scales, at which electron dynamics determines the plasma behaviour, are the next frontier in space and astrophysical plasma research. The analysis of astrophysical processes at these scales...
4.
Cosentino F, Marino A, Anile L, Moscatt V, Gussio M, Boscia V, et al.
Infect Dis Rep
. 2023 Feb;
15(1):70-83.
PMID: 36826348
Although the mortality rate among individuals diagnosed during the pre-Highly Active Antiretroviral Treatment era has been substantial, a considerable number of them survived. Our study aimed to evaluate the prevalence...
5.
Cosentino F, Moscatt V, Marino A, Pampaloni A, Scuderi D, Ceccarelli M, et al.
Biomed Rep
. 2022 Apr;
16(5):34.
PMID: 35386106
Since late December 2019, severe acute respiratory syndrome coronavirus 2 has spread across the world, which resulted in the World Health Organization declaring a global pandemic. Coronavirus disease 2019 (COVID-19)...
6.
Ceccarelli M, Marino A, Cosentino F, Moscatt V, Celesia B, Gussio M, et al.
Biomed Rep
. 2022 Jan;
16(2):10.
PMID: 34987794
Severe Acute Respiratory Syndrome-Coronavirus-2 (SARS-CoV-2) has been shown to increase the risk of thrombotic events due to a hypercoagulable state caused by several factors. The case of a 59-year-old woman...
7.
Marino A, Zafarana G, Ceccarelli M, Cosentino F, Moscatt V, Bruno G, et al.
Diagnostics (Basel)
. 2021 Dec;
11(12).
PMID: 34943573
HCV treatment became available for all infected patients regardless of their comorbidities, especially for HIV coinfected subjects, leading to an improvement in both clinical and immunological conditions. We retrospectively analyzed...
8.
Celesia B, Marino A, Del Vecchio R, Bruno R, Palermo F, Gussio M, et al.
Mediterr J Hematol Infect Dis
. 2019 Nov;
11(1):e2019063.
PMID: 31700588
Background: CD4+ lymphocyte cell count represents the main immunological marker used to monitor HIV infection. However, frequent monitoring may be unnecessary, could cause anxiety to the patient as well as...
9.
Pinzone M, Ceccarelli M, Venanzi Rullo E, Maresca M, Bruno R, Condorelli F, et al.
Biomed Rep
. 2019 Jan;
10(2):140-144.
PMID: 30675354
Chronic kidney disease (CKD) is an important cause of morbidity and mortality in HIV-infected individuals, even in the antiretroviral therapy (ART) era. Inflammatory cytokines and adipokines have been suggested to...
10.
Marino A, Caltabiano E, Zagami A, Onorante A, Zappala C, Locatelli M, et al.
BMC Infect Dis
. 2018 Dec;
18(1):693.
PMID: 30587143
Background: Highly active antiretroviral therapy has significantly changed the natural history of HIV infection, leading to a dramatic reduction of HIV-related morbidity and mortality. Late Presenters, Very Late Presenters and...